'New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine
Jansen, E.N.; van Laar, T.
Nederlands Tijdschrift Voor Geneeskunde 134(18): 889-891
1990
ISSN/ISBN: 0028-2162 PMID: 2345577 Document Number: 348532
Document emailed within 1 workday
Related Documents
Albani, C.; Zangger, I.; Fischer, G. 1992: Subcutaneous apomorphine infusion in the treatment of Parkinson disease Schweizerische Rundschau für Medizin Praxis 81(35): 1011-1015Pollak, P.; Champay, A.S.; Gaio, J.M.; Hommel, M.; Benabid, A.L.; Perret, J. 1990: Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease Revue Neurologique (Paris) 146(2): 116-122
Merello, M.; Leiguarda, R. 1995: Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine Medicina 55(1): 5-10
Giménez-Roldán, S.; García- Muñozguren, S. 2002: Use of apomorphine in Parkinson s disease Revista de Neurologia 35(7): 668-674
2005: Apomorphine (Apokyn) for advanced Parkinson's Disease Medical Letter on Drugs and Therapeutics 47(1200): 7-8
Castaigne, P.; Laplane, D.; Dordain, G. 1971: Clinical experimentation with apomorphine in Parkinson's disease Research Communications in Chemical Pathology and Pharmacology 2(2): 154-158
Montastruc, J.L.; Rascol, O.; Senard, J.M.; Houin, G.; Rascol, A. 1995: Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? Journal of Neural Transmission. Supplementum 45: 157-161
Pollak, P.; Gervason, C.L.; Deffond, D.; Perret, J.E. 1992: Apomorphine and Parkinson's disease. a major therapeutical progress La Revue du Praticien 42(5): 591-593
Schütz, H.; Erdmann, F.; Verhoff, M.A.; Weiler, G.ün. 2005: Reliability of % vol. declarations on labels of wine bottles Archiv für Kriminologie 215(3-4): 65-69
Leonhardt, T. 2000: Chronic fatigue syndrome--old wine in new bottles Lakartidningen 97(3): 182-184
Maggio, R.; Barbier, P.; Corsini, G.U. 1995: Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response Journal of Neural Transmission. Supplementum 45: 133-136
Bäckstrand, K; Kylsäter, M 2014: Old Wine in New Bottles? The Legitimation and Delegitimation of UN Public Private Partnerships for Sustainable Development from the Johannesburg Summit to the Rio+20 Summit Globalizations 11(3): 331-347
Chacón, J.é R.; Mata, M. 2012: Candidate patient for subcutaneous apomorphine injection Revista de Neurologia 55(Suppl 1): S7-S9
Grandas, F.J.; Sesar-Ignacio, Án. 2012: Subcutaneous continuous apomorphine infusion: treatment initiation and follow up Revista de Neurologia 55(Suppl 1): S21-S24
Ugwoke, M.I.; Agu, R.U.; Kinget, R.; Verbeke, N. 2003: Intravenous versus subcutaneous injections of apomorphine in rabbits: a pharmacokinetic paradox Bollettino Chimico Farmaceutico 142(8): 315-318
Giménez de Béjar, V.ón.; Carballo-Cordero, M. 2012: Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications Revista de Neurologia 55(Suppl 1): S25-S29
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262